CA2564592C - Compositions visant a ameliorer la sante du sein de la femme - Google Patents

Compositions visant a ameliorer la sante du sein de la femme Download PDF

Info

Publication number
CA2564592C
CA2564592C CA2564592A CA2564592A CA2564592C CA 2564592 C CA2564592 C CA 2564592C CA 2564592 A CA2564592 A CA 2564592A CA 2564592 A CA2564592 A CA 2564592A CA 2564592 C CA2564592 C CA 2564592C
Authority
CA
Canada
Prior art keywords
breast
women
dose
iodine
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2564592A
Other languages
English (en)
Other versions
CA2564592A1 (fr
Inventor
Keith E. Rushlow
Robert A. Shalwitz
Terry B. Mazer
Normanella T. Dewille
Tapas Das
Anand Seth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of CA2564592A1 publication Critical patent/CA2564592A1/fr
Application granted granted Critical
Publication of CA2564592C publication Critical patent/CA2564592C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pediatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des compositions et des procédés correspondants permettant de traiter la fibrose kystique du sein ou d'autres maladies ou états associés au sein. Ces compositions comprennent, par portion ou dose, entre 0 et environ 400 ?g de sélénium ; entre environ 100 mg et environ 6000 mg d'acide linoléique gamma ; et entre environ 0,15 mg et environ 5 mg d'iode. Dans des modes de réalisation concernant un aspect nutritionnel, lesdites compositions comprennent un ou plusieurs des éléments suivants : protéines, graisses, glucides, vitamines, et minéraux ; et fournissent entre environ 50 et environ 1000 kcal d'énergie par portion ou dose. L'invention concerne également des études in vitro qui montrent que certaines combinaisons d'acide linoléique gamma, d'iode et/ou de sélénium peuvent : 1) inhiber le cancer du sein ou la prolifération de cellules fibrokystiques ; 2) renforcer la fonction de jonctions serrées de cellules endothéliales et de cellules épithéliales mammaires dans des états sensibles aux oestrogènes ; et 3) réduire le risque d'invasion vasculaire par des cellules de cancer du sein.
CA2564592A 2004-04-29 2005-04-28 Compositions visant a ameliorer la sante du sein de la femme Expired - Lifetime CA2564592C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56662504P 2004-04-29 2004-04-29
US60/566,625 2004-04-29
PCT/US2005/014595 WO2005115472A2 (fr) 2004-04-29 2005-04-28 Compositions permettant d'ameliorer la sante des seins

Publications (2)

Publication Number Publication Date
CA2564592A1 CA2564592A1 (fr) 2005-12-08
CA2564592C true CA2564592C (fr) 2013-05-28

Family

ID=35376917

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2564592A Expired - Lifetime CA2564592C (fr) 2004-04-29 2005-04-28 Compositions visant a ameliorer la sante du sein de la femme

Country Status (2)

Country Link
CA (1) CA2564592C (fr)
WO (1) WO2005115472A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8663679B2 (en) 2004-04-29 2014-03-04 Abbott Laboratories Compositions for improving breast health in women
CN101087616A (zh) * 2004-09-21 2007-12-12 维拉科治疗学控股有限公司 用于治疗癌症的无机硒化合物
RU2420210C2 (ru) * 2006-03-23 2011-06-10 Нестек С.А. Высококалорийная питательная добавка
EP2004205A4 (fr) * 2006-03-29 2010-06-09 Velacor Therapeutics Pty Ltd Sélénium inorganique utilisé pour traiter des tumeurs bénines
GB2470001A (en) * 2009-05-05 2010-11-10 Alaa Hussein Al-Darraji Use of gamma linolenic acid in the treatment and diagnosis of cancer
US10034899B2 (en) 2013-11-27 2018-07-31 BioPharmX, Inc. Solid oral dosage form for breast symptoms
WO2021105345A1 (fr) * 2019-11-29 2021-06-03 Société des Produits Nestlé S.A. Compositions et procédés pour le traitement de la mastite

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US6019970A (en) * 1985-07-31 2000-02-01 Ghent William R. Treatment of iodine deficiency diseases
EP0707850A1 (fr) * 1994-09-21 1996-04-24 Scotia Holdings Plc Utilisation d'acides gras polyinsaturés pour la fabrication d'un médicament pour le traitement des douleurs des seins
AT405477B (de) * 1996-04-03 1999-08-25 Norbert Mag Fuchs Kombinationspräparat
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
EP1395124B1 (fr) * 2001-05-23 2006-04-12 Nutricopia, Inc. Dessert glace nutritif et procedes pour le produire

Also Published As

Publication number Publication date
WO2005115472A2 (fr) 2005-12-08
WO2005115472A3 (fr) 2006-02-02
CA2564592A1 (fr) 2005-12-08

Similar Documents

Publication Publication Date Title
Wood et al. β-Carotene and selenium supplementation enhances immune response in aged humans
AU2003266400C1 (en) Leucine-enriched nutritional compositions
US8663679B2 (en) Compositions for improving breast health in women
US20040048919A1 (en) Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
CN103476421B (zh) 组合物、糖代谢改善剂以及糖代谢改善方法
US8927033B2 (en) Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and food or beverage
WO2000066133A1 (fr) Complements alimentaires
WO2012097064A1 (fr) Compositions nutritionnelles et procédés pour contrôler le glucose dans le sang
WO2012097061A1 (fr) Compositions nutritionnelles et procédés pour améliorer le métabolisme protéique des muscles squelettiques
CA2564592C (fr) Compositions visant a ameliorer la sante du sein de la femme
US20240150707A1 (en) Novel strain of lactobacillus gasseri lm1065 separated from breast milk, and composition of relieving premenstrual syndrome comprising the strain or its culture fluid
JP2011256188A (ja) 糖代謝改善組成物
EP2435039B1 (fr) Combinaison d'une source de leucine et d' une source d'acide gras insaturé omega-3 pour le traitement de l'hypercalcémie
CA2987143A1 (fr) Composition et ses utilisations
JP2011012005A (ja) 高脂血症改善剤
Walker et al. Unexpected benefit of sorbitol placebo in Mg intervention study of premenstrual symptoms: implications for choice of placebo in RCTs
CN106360742A (zh) 一种用于肥胖或减脂手术患者的营养食品组合物
JP4838894B2 (ja) 糖代謝改善剤
JP2008533113A (ja) 体重増調整組成物の製造におけるタマネギ抽出物の使用
CN112471503A (zh) 一种可增强免疫力并营养干预结直肠癌的蓝莓粉复方固体制剂及其制备方法和应用
JP6770726B1 (ja) メタボリックシンドロームの予防または改善剤
Trentman et al. Acarbose–Creatine
KR100450055B1 (ko) 두과 식물을 주성분으로 함유하는 체질개선용 식품 조성물및 그로부터 제조되는 식품
JP2006206474A (ja) 機能性食品及び医薬
JP2024038951A (ja) Ａｋｋｅｒｍａｎｓｉａ属細菌増殖促進剤

Legal Events

Date Code Title Description
EEER Examination request
H11 Ip right ceased following rejected request for revival

Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED

Effective date: 20251029

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20251106